Capstone Investment Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.44M Buy
54,715
+2,840
+5% +$198K 0.01% 504
2025
Q4
$3.44M Sell
51,875
-67,564
-57% -$4.37M 0.01% 463
2025
Q3
$8.04M Buy
119,439
+103,277
+639% +$8.17M 0.02% 358
2025
Q2
$1.41M Sell
16,162
-20,452
-56% -$1.6M ﹤0.01% 752
2025
Q1
$2.5M Sell
36,614
-17,648
-33% -$1.44M 0.01% 631
2024
Q4
$4.22M Sell
54,262
-8,740
-14% -$647K 0.01% 605
2024
Q3
$4.22M Buy
63,002
+32,294
+105% +$2.65M 0.01% 507
2024
Q2
$3.48M Buy
30,708
+26,476
+626% +$3.35M 0.01% 556
2024
Q1
$587K Buy
4,232
+1,178
+39% +$148K ﹤0.01% 1470
2023
Q4
$379K Sell
3,054
-5,035
-62% -$514K ﹤0.01% 1477
2023
Q3
$755K Buy
+8,089
New +$912K ﹤0.01% 1097
2023
Q1
Sell
-5,494
Closed -$615K 1590
2022
Q4
$622K Sell
5,494
-16,869
-75% -$1.85M ﹤0.01% 1067
2022
Q3
$1.8M Buy
22,363
+16,095
+257% +$1.36M 0.01% 802
2022
Q2
$467K Buy
+6,268
New +$572K ﹤0.01% 1268
2021
Q2
Sell
-10,248
Closed -$984K 1751
2021
Q1
$921K Sell
10,248
-10,720
-51% -$1.01M ﹤0.01% 1150
2020
Q4
$1.94M Buy
+20,968
New +$1.87M 0.01% 883

Other funds holding DXCM

Capstone Investment Advisors's DXCM Position: Q1 2026 in Review

Capstone Investment Advisors increased its DexCom (DXCM) stake by 5.5% in Q1 2026, buying an estimated $198K and bringing the position to 54,715 shares worth $3.44M. The position accounts for 0.01% of the portfolio, ranked #504.

Capstone Investment Advisors first reported a position in DXCM in Q4 2020 and has held it in 16 quarters since. The position peaked at $8.04M in Q3 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Capstone Investment Advisors held 54,715 shares of DexCom worth $3.44M as of Q1 2026.
  • Capstone Investment Advisors bought 2,840 DexCom shares in Q1 2026, an estimated $198K.
  • DexCom made up 0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #504 holding.
  • Capstone Investment Advisors first reported a position in DexCom in Q4 2020 and has held it in 16 quarters since.
  • Capstone Investment Advisors's DexCom position peaked at $8.04M in Q3 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.